Skip to content
MedsAcross

Medicine

Qvar Redihaler 80 mcg inhaler

Beclomethasone dipropionate · Inhalation · Teva Respiratory
Available on requestPrescription onlyUS FDA

Qvar Redihaler 80 mcg inhaler is a prescription medicine containing Beclomethasone dipropionate for inhalation use, marketed by Teva Respiratory, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25ºC (77ºF). Excursions between 15ºC and 30ºC (59ºF and 86ºF) are…

Key facts

Active ingredient (INN)
Beclomethasone dipropionate
Brand
Qvar Redihaler
Strength
80 mcg
Dosage form
Inhaler
Route
Inhalation
Packs
1 inhaler
Marketing authorisation holder
Teva Respiratory
Manufacturers
Teva RespiratoryA-S Medication Solutions
Origin register
US FDA, United States
Storage
Store at 25ºC (77ºF). Excursions between 15ºC and 30ºC (59ºF and 86ºF) are permitted. For optimal results, QVAR REDIHALER should be at room temperature when used. Exposure to temperatures above 49ºC (120ºF) may cause bursting. Do not use or store near heat or open flame.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A07EA07 Beclomethasone dipropionate
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 February 2018
Identifiers
RxCUI 1998771, 1998772, 1998773 +1DailyMed set ID ccd3aaec-4892-40d0-ad60-3e570178fbe1, 2814cf81-392e-4dd4-9816-ae7e6e5ec84f, cada897a-264e-450d-ae00-36e7fe747080NDC 50090-3459, 50090-5032, 59310-304Application NDA207921

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 inhaler in 1 carton / 1 canister in 1 inhaler / 120 aerosol, metered in 1 canister59310-304-80Teva Respiratory15 February 2018
1 inhaler in 1 carton / 1 canister in 1 inhaler / 120 aerosol, metered in 1 canister50090-3459-0A-S Medication Solutions21 May 2018
1 inhaler in 1 carton / 1 aerosol, metered in 1 inhaler50090-5032-0A-S Medication Solutions30 April 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 12 May 1976Drugs@FDA
EU (EMA)Application withdrawnEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Beclomethasone dipropionate 80 mcg inhaler.

Compare 1

Other strengths and forms of Beclomethasone dipropionate

Clinical summary

Beclomethasone dipropionate is a corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. MedsAcross supplies Beclomethasone dipropionate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Beclomethasone dipropionate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Qvar Redihaler 80 mcg inhaler for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.